Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Century Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
IPSC
Nasdaq
8731
https://www.centurytx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Century Therapeutics Inc
Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
- Apr 23rd, 2024 11:00 am
Century buys a startup, raises funding in cell therapy expansion
- Apr 11th, 2024 12:25 pm
Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
- Apr 11th, 2024 11:00 am
Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting
- Apr 8th, 2024 8:05 pm
Century Therapeutics (NASDAQ:IPSC) Will Have To Spend Its Cash Wisely
- Mar 29th, 2024 12:50 pm
Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors
- Mar 25th, 2024 11:00 am
Amneal (AMRX) Stock Jumps 7.3%: Will It Continue to Soar?
- Mar 20th, 2024 10:11 am
Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
- Mar 19th, 2024 11:00 am
Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates
- Mar 14th, 2024 11:30 am
Century Therapeutics Inc (IPSC) COO Adrienne Farid Sells 53,515 Shares
- Mar 9th, 2024 4:55 am
How Much Upside is Left in Century Therapeutics, Inc. (IPSC)? Wall Street Analysts Think 193.4%
- Mar 7th, 2024 2:55 pm
Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
- Mar 5th, 2024 11:03 pm
Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
- Feb 1st, 2024 12:00 pm
Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits
- Dec 9th, 2023 5:00 pm
Century (IPSC) Up 36% on FDA Nod to Begin Phase I Lupus Study
- Dec 7th, 2023 4:01 pm
Century Therapeutics, Inc.'s (NASDAQ:IPSC) largest shareholders are public companies who were rewarded as market cap surged US$47m last week
- Dec 7th, 2023 10:14 am
Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus
- Dec 6th, 2023 12:30 pm
Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus Erythematosus
- Dec 6th, 2023 12:30 pm
Penny Stock Jackpots: 3 High-Stakes Picks With 10-Bagger Potential
- Dec 5th, 2023 1:55 pm
Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference
- Nov 21st, 2023 12:00 pm
Scroll